0000905718-18-000546.txt : 20180530 0000905718-18-000546.hdr.sgml : 20180530 20180530080014 ACCESSION NUMBER: 0000905718-18-000546 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180530 DATE AS OF CHANGE: 20180530 EFFECTIVENESS DATE: 20180530 FILER: COMPANY DATA: COMPANY CONFORMED NAME: biOasis Technologies Inc. CENTRAL INDEX KEY: 0001703978 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-313471 FILM NUMBER: 18866516 BUSINESS ADDRESS: STREET 1: 14 WATER STREET CITY: GUILFORD STATE: CT ZIP: 06437 BUSINESS PHONE: 1-203-390-7395 MAIL ADDRESS: STREET 1: 14 WATER STREET CITY: GUILFORD STATE: CT ZIP: 06437 D 1 primary_doc.xml X0708 D LIVE 0001703978 biOasis Technologies Inc. 14 WATER STREET GUILFORD CT CONNECTICUT 06437 1-203-390-7395 BRITISH COLUMBIA, CANADA W.R. Partners Ltd. None Corporation true Deborah Rathjen c/o biOasis Technologies Inc. 14 WATER STREET GUILFORD CT CONNECTICUT 06437 Director Nancy Stagliano c/o biOasis Technologies Inc. 14 WATER STREET GUILFORD CT CONNECTICUT 06437 Director Maha Radhakrishnan c/o biOasis Technologies Inc. 14 WATER STREET GUILFORD CT CONNECTICUT 06437 Director Mark Day c/o biOasis Technologies Inc. 14 WATER STREET GUILFORD CT CONNECTICUT 06437 Executive Officer Director Biotechnology Decline to Disclose 06b false 2018-05-17 false true UNITS CONSISTING OF ONE COMMON SHARE AND ONE SHARE PURCHASE WARRANT false 0 Roth Capital Partners, LLC 15407 None None 888 SAN CLEMENTE SUITE 400 NEWPORT BEACH CA CALIFORNIA 92660 All States false 718529 718529 0 U.S. dollar amounts are based on the Bank of Canada daily average exchange rate reported on May 17, 2018, which was Cdn $0.78 = US $1.00. Actual exchange rates will be specific to dates of closing. Excludes sales to offshore investors. false 6 50297 true 0 U.S. dollar amounts based on the Bank of Canada daily average exchange rate reported on May 17, 2018. 0 true Some of the proceeds may be used for general working capital purposes including the payment of salaries and other fees to those listed in Item 3. false biOasis Technologies Inc. /s/ Mark Day Mark Day President and CEO 2018-05-30